ResearcherUniversitätsmedizin GöttingenActive in the last 2 years
Rebecca Diya Samuel
Matched on ORCID iD 0009-0002-0603-0406. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2025: 2 papers · 2026: 1 paper
Papers 3
- Tumor-intrinsic dichotomy shapes cellular heterogeneity in pancreatic cancer. Co-author DOI 10.1016/j.trecan.2025.11.003↗
- Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. Co-author DOI 10.1038/s41467-024-55330-7↗
- TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. Co-author DOI 10.1126/sciadv.adu2339↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shiv K. Singh · 3 shared papers, 2025–2026 · strength 1.03
- Paper Tumor-intrinsic dichotomy shapes cellular heterogeneity in pancreatic cancer. DOI 10.1016/j.trecan.2025.11.003↗
- Paper TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. DOI 10.1126/sciadv.adu2339↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Laura Urbach · 2 shared papers, 2025 · strength 0.40
- Paper TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. DOI 10.1126/sciadv.adu2339↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Lukas Klein · 2 shared papers, 2025 · strength 0.40
- Paper TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. DOI 10.1126/sciadv.adu2339↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Elisabeth Heßmann · 2 shared papers, 2025 · strength 0.40
- Paper TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. DOI 10.1126/sciadv.adu2339↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Volker Ellenrieder · 2 shared papers, 2025 · strength 0.40
- Paper TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer. DOI 10.1126/sciadv.adu2339↗
- Paper Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer. DOI 10.1038/s41467-024-55330-7↗
- Michael B. Ghadimi · 1 shared paper, 2025 · strength 0.22
- Ramona Schulz‐Heddergott · 1 shared paper, 2025 · strength 0.22
- Ulrich Sax · 1 shared paper, 2025 · strength 0.22
- Nelson Dusetti · 1 shared paper, 2025 · strength 0.22
- Argyris Papantonis · 1 shared paper, 2025 · strength 0.18
- Elisa Espinet Espinet · 1 shared paper, 2025 · strength 0.18
- Rama Khokha · 1 shared paper, 2025 · strength 0.18
- Uday Kishore · 1 shared paper, 2025 · strength 0.18
- Muhammad Umair Latif · 1 shared paper, 2025 · strength 0.18
- Andreas Trumpp · 1 shared paper, 2025 · strength 0.18
- Barbara T. Grünwald · 1 shared paper, 2025 · strength 0.18
- Kazeera Aliar · 1 shared paper, 2025 · strength 0.18
- Niklas Krebs · 1 shared paper, 2025 · strength 0.18
- Mengyu Tu · 1 shared paper, 2025 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.